Intravenous immunoglobulin therapy in multiple sclerosis: Progress from remyelination in the Theiler's virus model to a randomised, doubleblind, placebo-controlled clinical trial

John H. Noseworthy, Peter C. O'Brien, Baziel G.M. Van Engelen, Moses Rodriguez

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint Dive into the research topics of 'Intravenous immunoglobulin therapy in multiple sclerosis: Progress from remyelination in the Theiler's virus model to a randomised, doubleblind, placebo-controlled clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences